To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in securities by directors and by directors of a major subsidiary

Release Date: 27/11/2012 09:00
Code(s): APN     PDF:  
Wrap Text
Dealing in securities by directors and by directors of a major subsidiary

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


DEALING IN SECURITIES BY DIRECTORS AND BY DIRECTORS OF A MAJOR
SUBSIDIARY

In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:

Shareholders are referred to the SENS announcement released on
23 November 2012 regarding the dealing in securities by directors and
by directors of a major subsidiary. The director and directors of a
major subsidiary listed below have elected to have a portion of the
shares released to them in terms of the SA Management Deferred
Incentive Bonus Scheme sold to cover the tax liabilities arising from
the release of the deferred incentive bonus shares to them:

BY A DIRECTOR OF THE COMPANY:
Director                           :   Michael Guy Attridge
Company                            :   Aspen Pharmacare Holdings Limited
Date of transaction                :   26 November 2012
Number of shares sold to pay tax   :   9 752
Value of shares sold               :   R1 542 668.88
Selling price                      :   R158.19
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

BY DIRECTORS OF A MAJOR SUBSIDIARY:
Director                          :    Sean Matthew Capazorio
Company                           :    Pharmacare Limited
Date of transaction               :    26 November 2012
Number of shares sold to pay tax :     3 283
Value of shares sold              :    R519 377.77
Selling price                     :    R158.19
Class of securities               :    Ordinary shares
Nature of interest                :    Direct beneficial
Clearance obtained                :    Yes

Director                           :   Mziwandile Noel Guliwe
Company                            :   Pharmacare Limited
Date of transaction                :   26 November 2012
Number of shares sold to pay tax   :   1 155
Value of shares sold               :   R182 709.45
Selling price                      :   R158.19
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

All share sales are on-market trades.

Durban
27 November 2012

Sponsor
Investec Bank Limited

Date: 27/11/2012 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story